TRIPS-plus agreements

GPTKB entity

Statements (54)
Predicate Object
gptkbp:instance_of gptkb:organization
gptkbp:bfsLayer 4
gptkbp:bfsParent gptkb:Agreement_on_Trade-Related_Aspects_of_Intellectual_Property_Rights
gptkbp:affects developing countries
cultural industries
gptkbp:aims_to enhance protection of intellectual property
gptkbp:can_create barriers to entry
gptkbp:can_lead_to trade disputes
increased litigation
knowledge monopolies
gptkbp:enforces national governments
https://www.w3.org/2000/01/rdf-schema#label TRIPS-plus agreements
gptkbp:impact innovation
gptkbp:includes copyright protection
patent protection
trademark protection
gptkbp:influences national laws
gptkbp:is_associated_with trade liberalization
gptkbp:is_connected_to trade facilitation
copyright treaties
gptkbp:is_criticized_for lack of flexibility
favoring developed countries
restricting access to medicines
impact on access to information
impact on creativity
gptkbp:is_discussed_in gptkb:international_forums
academic literature
gptkbp:is_evaluated_by legal scholars
economic impact studies
policy analysts
gptkbp:is_implemented_in bilateral agreements
gptkbp:is_influenced_by global economic trends
political factors
gptkbp:is_linked_to gptkb:economic_development
foreign direct investment
gptkbp:is_opposed_by civil society organizations
public health advocates
gptkbp:is_part_of gptkb:TRIPS_Agreement
international trade law
trade negotiations
WTO agreements
global trade policy
gptkbp:is_promoted_by international organizations
gptkbp:is_related_to free trade agreements
digital rights management
patent law
technology transfer
gptkbp:is_subject_to legal challenges
international negotiations
gptkbp:is_supported_by pharmaceutical companies
industry groups
gptkbp:negotiated_by WTO member countries
gptkbp:related_to intellectual property rights
gptkbp:requires enforcement of IP rights